Nils Heyne

Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation

Julien Zuber, Moglie Le Quintrec, Saoussen Krid et al. · American Journal of Transplantation · 2012 · 259 citations

Medicine, Nephrology, Pharmacotherapy +14

Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy

Anja Schork, Janine Saynisch, Andreas Vosseler et al. · Cardiovascular Diabetology · 2019 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Éric Rondeau, Marie Scully, Gema Ariceta et al. · Kidney International · 2020 · 219 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT

Lutz Fischer, J. Klempnauer, Susanne Beckebaum et al. · American Journal of Transplantation · 2012 · 189 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17

Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia

Karina Althaus, Peter Mӧller, Günalp Uzun et al. · Haematologica · 2021 · 136 citations · Full text

Medicine, Hematology, Immunology +15